Kaiku Health, a digital therapeutics company for oncology, has developed a daily symptom monitoring module for COVID-19 patients in co-operation with the leading Swiss university hospital group, the Geneva University Hospitals (HUG).
PROHUG, the name of the Kaiku Health service at HUG, will now be used for remote monitoring of patients diagnosed with or suspected of having a COVID-19 infection. The condition of post-hospitalized patients in the Canton of Geneva, as well as those who are diagnosed or suspected of having the infection, will be remotely evaluated for rapid identification of clinical deterioration or improvement.
Monitoring will take place through a digital platform used both by patients and health care professionals. Based on the patients’ daily symptom reports, the platform automatically triages patients’ incoming daily symptom reports and sends notifications to the dedicated COVID-19 care personnel for further assessment. According to clinical evaluation, the patient is either suggested to continue follow-up or come to the emergency room where a team will be waiting for them for hospital admission.
“Efficient recognition of patients who need hospitalisation is increasingly important in a situation where health care resources are strained. Digital symptom monitoring can also be used to recognise patients with COVID-19 infections when testing capacity is overburdened”, explains Vesa Kataja, the Chief Medical Officer of Kaiku Health.
Kaiku Health platform has already been in routine use at the Geneva University Hospitals for symptom management of cancer patients. In March, the use of the platform was decided to be rapidly extended for remote monitoring of COVID-19 symptoms.
“The importance of remote patient management and ensuring hospital workflows are now more important than ever. The pandemic calls for new processes and solutions through close cooperation between healthcare providers and the health tech industry, of which PROHUG has been a great example. We already had the technology and expertise in highly specialized cancer care and it could be adapted quickly to support hospitals fighting COVID-19. Our priority now is to support our partner hospitals through this challenging time”, adds Lauri Sippola, the CEO of Kaiku Health.
About Kaiku Health
Kaiku Health is a digital health intervention platform classified as a Medical Device in cancer care. Its algorithms screen symptoms, notify care team and provide personalised support for patients. Kaiku Health has modules for over 25 cancer types across different cancer care pathways and is currently in use in over 40 European cancer clinics and hospitals. For more information, visit: www.kaikuhealth.com
For questions and more information, contact:
Lauri Sippola
CEO, Kaiku Health
+358 40 744 7481
lauri.sippola@kaikuhealth.com